Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
novartis
5
×
biotech
deals
gene therapy
national
national top stories
boston blog main
boston top stories
cancer
medicaid
new york blog main
new york top stories
pfizer
bill cassidy
biogen
boulder/denver blog main
boulder/denver top stories
car-t
celgene
clinical trials
crispr
detroit blog main
detroit top stories
fda
genentech
hemophilia
indiana blog main
indiana top stories
ipo
johnson & johnson
mark warner
medicare
meiragtx
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
What
gene
5
×
therapy
bio
roundup
access
advanced
age
alzheimer’s
becker
bigger
biggest
billions
capacity
car
cell
chemistry
cmc
come
companies
consistent
consolidation
controls
crispr
deal
different
dollars
drug
eaton
emerging
ensure
fail
falcon
fda
focus
gave
healthcare
impact
increases
j
johnson
Language
unset
Current search:
novartis
×
gene
×
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy